107 related articles for article (PubMed ID: 15589822)
41. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
42. [Study on telomerase activity and expression of hTERT, c-myc and bcl-2 during terminal differentiation of HL-60 cells induced by retinoic acid].
Wu LD; Chen YZ; Li NN; Wu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):395-9. PubMed ID: 12513735
[TBL] [Abstract][Full Text] [Related]
43. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
44. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.
Shen M; Yen A
Cancer Res; 2008 Nov; 68(21):8761-9. PubMed ID: 18974118
[TBL] [Abstract][Full Text] [Related]
45. Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines.
Melkoumian ZK; Martirosyan AR; Strobl JS
Int J Cancer; 2002 Nov; 102(1):60-9. PubMed ID: 12353235
[TBL] [Abstract][Full Text] [Related]
46. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23.
Chou YH; Yung BY
Biochem Biophys Res Commun; 1995 Dec; 217(1):313-25. PubMed ID: 8526928
[TBL] [Abstract][Full Text] [Related]
47. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
48. Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2.
Nakamura M; Matsuo T; Stauffer J; Neckers L; Thiele CJ
Cell Death Differ; 2003 Feb; 10(2):230-9. PubMed ID: 12700651
[TBL] [Abstract][Full Text] [Related]
49. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
50. Retinoic acid-mediated decrease of G (alpha S) protein expression: involvement of G (alpha S) in the differentiation of HL-60 myeloid cells.
Meissner JD; Brown GA; Mueller WH; Scheibe RJ
Exp Cell Res; 1996 May; 225(1):112-21. PubMed ID: 8635503
[TBL] [Abstract][Full Text] [Related]
51. Docosahexaenoic acid-containing phosphatidylethanolamine enhances HL-60 cell differentiation by regulation of c-jun and c-myc expression.
Ishigamori H; Hosokawa M; Kohno H; Tanaka T; Miyashita K; Takahashi K
Mol Cell Biochem; 2005 Jul; 275(1-2):127-33. PubMed ID: 16335792
[TBL] [Abstract][Full Text] [Related]
52. Rapid and transient decrease of N-myc expression in retinoic acid-induced differentiation of OTF9 teratocarcinoma stem cells.
Kato K; Kanamori A; Kondoh H
Mol Cell Biol; 1990 Feb; 10(2):486-91. PubMed ID: 2405249
[TBL] [Abstract][Full Text] [Related]
53. Antisense knockout of HOXB4 blocks 1,25-dihydroxyvitamin D3 inhibition of c-myc expression.
Pan Q; Simpson RU
J Endocrinol; 2001 Apr; 169(1):153-9. PubMed ID: 11250656
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of cytochromes P450 in growth-stimulated rat hepatocytes: role of c-Myc induction and impaired C/EBP binding to DNA.
Tinel M; Berson A; Elkahwaji J; Cresteil T; Beaune P; Pessayre D
J Hepatol; 2003 Aug; 39(2):171-8. PubMed ID: 12873812
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.
Subong EN; Shue MJ; Epstein JI; Briggman JV; Chan PK; Partin AW
Prostate; 1999 Jun; 39(4):298-304. PubMed ID: 10344220
[TBL] [Abstract][Full Text] [Related]
56. Decreased accumulation and dephosphorylation of the mitosis-specific form of nucleophosmin/B23 in staurosporine-induced chromosome decondensation.
Lu YY; Lam CY; Yung BY
Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):321-7. PubMed ID: 8694782
[TBL] [Abstract][Full Text] [Related]
57. Retinoic-acid-induced modulation of c-myc not dependent on its continued presence: possible role in pre-commitment for HL-60 cells.
Guernsey DL; Yen A
Int J Cancer; 1988 Oct; 42(4):576-81. PubMed ID: 2459072
[TBL] [Abstract][Full Text] [Related]
58. Evidence for the ability of nucleophosmin/B23 to bind ATP.
Chang JH; Lin JY; Wu MH; Yung BY
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):539-44. PubMed ID: 9445380
[TBL] [Abstract][Full Text] [Related]
59. Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
Momparler RL; Doré BT; Momparler LF
Cancer Lett; 1990 Oct; 54(1-2):21-8. PubMed ID: 1698532
[TBL] [Abstract][Full Text] [Related]
60. Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells.
You BJ; Huang IJ; Liu WH; Hung YB; Chang JH; Yung BY
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):683-90. PubMed ID: 10619186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
